# Eval Result: regression-suite-verify-bug-fix

## Evaluation Target

- Skill: `regression-suite`
- Test case: verify-bug-fix
- Test set: QA availability evals
- Entry: workspace `eval-1-verify-bug-fix`
- Latest result: PASS - fresh Codex subagent validation on 2026-06-23 after QA owner split fix

## With Skill

- Reuses the original bug report, fix notes, and QA environment context.
- Verifies the fix path and adjacent regression risk instead of checking only the happy path.
- Produces a clear pass/fail/blocked regression conclusion.
- Reads the function-tree E2E suite, flow index, case file, script snippet, prior results, and reports when available before execution.
- Keeps `feature-update` scoped to the fixed flow, direct impact paths, shared components, adjacent flows, and related state branches; reserves all active E2E TC coverage for `release`.
- Requires same-`feature_path` PRD/TRD expectation alignment and a confirmed `docs/engineer/{feature_path}/IMPLEMENTATION_PLAN.md` before updating or executing acceptance TC for existing-feature changes or bug fixes.
- Routes PRD/path ambiguity to `pm-agent:idea-to-spec`, TRD gaps to `engineer-agent:trd-gen`, and missing or mismatched implementation plans to `engineer-agent:feature-implementor`.
- Treats a missing platform version as `blocked`, avoids `unknown`, and appends E2E results under `results/TC-NNN-<short-slug>/{platform-version}/` without overwriting history.
- Separates run status from evidence confidence and includes a release recommendation.

## Baseline

- More likely to verify only the direct symptom.
- Provides weaker linkage back to original bug evidence.
- More likely to over-expand a local `feature-update` regression into release-wide coverage or skip durable E2E case memory.

## Failures

- None. Current `regression-suite` instructions satisfy all eval assertions for evidence reuse, QA case reuse, fix verification, adjacent regression scope, PRD/TRD and implementation-plan gate, owner routing, platform-version archive rules, and release recommendation.

## Next Steps

- Keep this eval for regression evidence reuse.
- Runtime transcripts, verdicts, timing, and diagnostics should not be committed.
